C2N Diagnostics lands $10m cash injection from Samsung
C2N Diagnostics has received a $10m strategic investment out of Samsung’s life science investment fund. The US company said the cash …
Post
-
-
Vave Health launches Universal Wireless Probe for full-body imaging
Vave Health has launched Universal Wireless Probe, a handheld device aimed at improving accuracy, diagnostics and efficiency in various clinical …
-
Helius joins BCI landscape with new subsidiary
Helius Medical Technologies is muscling in on the promising brain computer interface (BCI) field with the launch of a new …
-
Roche Diagnostics supports UK eye cancer AI initiative
Roche Diagnostics is collaborating with the University of Liverpool to launch the Eye Cancer Artificial Intelligence Digital Bioresource (EYE-CAN-AID), a …
-
University of Turku develops carbon nanotube sensors for health monitoring
Researchers at Finland’s University of Turku have developed sensors from single-wall carbon nanotubes, which may be suited for continuous health …
-
FDA approves early feasibility study of Valcare’s transcatheter device
The US Food and Drug Administration (FDA) has granted approval for Valcare Medical’s investigational device exemption application, allowing it to …
-
Vivani treats first patient with long-lasting drug implant for weight loss
A day after announcing a business split-off to focus on weight loss and diabetes implants, Vivani Medical has implanted the …
-
FDA clears Perfuze’s Zipline access catheter for stroke treatment
The US Food and Drug Administration (FDA) has cleared Perfuze’s Zipline single-use access catheter for acute ischemic stroke (AIS) procedures. The …
-
Proteomics announces Australian launch of predictive diabetic kidney test
Proteomics International Laboratories has launched the PromarkerD diabetic kidney disease (DKD) predictive test in Australia. The test is said to predict …
-
MicroTransponder receives $65m to advance stroke care with Vivistim
MicroTransponder has received $65m in a Series F financing round, which aims to enhance its stroke care offerings with the …
-
Nearly a third of FDA medical device adverse event reports filed late
Almost a third of medical device adverse events (AEs) were reported by manufacturers later than the US Food and Drug …
-
FDA grants 510(k) clearance for J&J MedTech’s Monarch Quest
The US Food and Drug Administration (FDA) has granted 510(k) clearance for Johnson & Johnson (J&J) MedTech’s Monarch Quest intended …
-
Renal denervation: An advanced procedure to relieve hypertension
Hypertension, or high blood pressure, is a global health crisis affecting an estimated 1.3 billion people. Often referred to as …
-
Vivani Medical to spin-off neurostim business Cortigent as public company
Vivani Medical will spin off Cortigent, its neurostimulation business, as an independently publicly traded company as it looks to prioritise …
-
Vantis Health completes €10m funding round to advance primary care
Vantis Health has completed a €10m ($10.9m) Series A funding round led by Angelini Ventures’, the investment arm of Italian …
